The German Capital Region is one of the most important biotech hubs in Europe. Around twenty pharmaceutical companies with 10,000 employees and 230 biotech firms with approx. 5,300 employees are located here.
Many businesses from the life-sciences sector, including concerns like Takeda, LGC and Thermo Fisher Scientific, operate facilities in Brandenburg. The region specifically supports the biotechnology and pharmaceutical industry with tailor-made and attractive grants for investment and R&D projects, while equity capital is made available to technology-oriented businesses. Moreover, five technology parks offer companies office and lab space at reasonable rates.
As a central point of contact, the WFBB offers life-sciences companies who are considering investing in Brandenburg a comprehensive range of services that includes support in finding a suitable location, advice on funding possibilities and arranging contacts with cooperation partners.